[go: up one dir, main page]

IL174641A0 - Polymeric pharmaceutical compositions containing an anti-fibrotic agent - Google Patents

Polymeric pharmaceutical compositions containing an anti-fibrotic agent

Info

Publication number
IL174641A0
IL174641A0 IL174641A IL17464106A IL174641A0 IL 174641 A0 IL174641 A0 IL 174641A0 IL 174641 A IL174641 A IL 174641A IL 17464106 A IL17464106 A IL 17464106A IL 174641 A0 IL174641 A0 IL 174641A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
fibrotic agent
polymeric pharmaceutical
polymeric
Prior art date
Application number
IL174641A
Original Assignee
Angiotech Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/986,231 external-priority patent/US20050181977A1/en
Application filed by Angiotech Int Ag filed Critical Angiotech Int Ag
Publication of IL174641A0 publication Critical patent/IL174641A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Surgery (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL174641A 2003-11-20 2006-03-30 Polymeric pharmaceutical compositions containing an anti-fibrotic agent IL174641A0 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US52390803P 2003-11-20 2003-11-20
US52522603P 2003-11-24 2003-11-24
US52654103P 2003-12-03 2003-12-03
US56656904P 2004-04-28 2004-04-28
US58686104P 2004-07-09 2004-07-09
US61107704P 2004-09-17 2004-09-17
US10/986,231 US20050181977A1 (en) 2003-11-10 2004-11-10 Medical implants and anti-scarring agents
PCT/US2004/039389 WO2005051452A2 (en) 2003-11-20 2004-11-22 Polymer compositions and methods for their use

Publications (1)

Publication Number Publication Date
IL174641A0 true IL174641A0 (en) 2006-08-20

Family

ID=34637499

Family Applications (1)

Application Number Title Priority Date Filing Date
IL174641A IL174641A0 (en) 2003-11-20 2006-03-30 Polymeric pharmaceutical compositions containing an anti-fibrotic agent

Country Status (6)

Country Link
EP (1) EP1684819A2 (en)
JP (1) JP2007517543A (en)
AU (1) AU2004293071A1 (en)
CA (1) CA2536181A1 (en)
IL (1) IL174641A0 (en)
WO (2) WO2005051452A2 (en)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003272471B2 (en) 2002-09-18 2010-10-07 Trustees Of The University Of Pennsylvania Method of inhibiting choroidal neovascularization
JP2007505932A (en) 2003-09-18 2007-03-15 マクサイト， インコーポレイテッド Transscleral delivery
CA2536042A1 (en) * 2003-11-10 2005-06-02 Angiotech International Ag Medical implants and anti-scarring agents
US8663639B2 (en) 2005-02-09 2014-03-04 Santen Pharmaceutical Co., Ltd. Formulations for treating ocular diseases and conditions
AU2006213673A1 (en) 2005-02-09 2006-08-17 Santen Pharmaceutical Co., Ltd. Formulations for ocular treatment
EP1894582A1 (en) * 2005-06-24 2008-03-05 Tokyo Medical and Dental University Method for control of drug elution rate and composition for coating of drug-eluting stent
JP2007135965A (en) * 2005-11-21 2007-06-07 Tohoku Univ Indwelling multifunctional stent and method for producing the same
BRPI0707612B8 (en) 2006-02-09 2021-05-25 Macusight Inc sealed vessel and liquid formulations contained therein
US8222271B2 (en) 2006-03-23 2012-07-17 Santen Pharmaceutical Co., Ltd. Formulations and methods for vascular permeability-related diseases or conditions
EP3047860B1 (en) 2006-07-20 2024-08-28 OrbusNeich Medical Pte. Ltd. Bioabsorbable polymeric composition for a medical device
US7959942B2 (en) 2006-10-20 2011-06-14 Orbusneich Medical, Inc. Bioabsorbable medical device with coating
EP2073754A4 (en) 2006-10-20 2012-09-26 Orbusneich Medical Inc Bioabsorbable polymeric composition and medical device background
US9023114B2 (en) 2006-11-06 2015-05-05 Tyrx, Inc. Resorbable pouches for implantable medical devices
CA2667867C (en) * 2006-11-06 2015-02-24 Tyrx Pharma, Inc. Resorbable pouches for implantable medical devices
US7801624B1 (en) 2007-01-16 2010-09-21 Pacesetter, Inc. Reduced perforation distal tip for an implantable cardiac electrotherapy lead
US11064964B2 (en) 2007-03-08 2021-07-20 Sync-Rx, Ltd Determining a characteristic of a lumen by measuring velocity of a contrast agent
US11197651B2 (en) 2007-03-08 2021-12-14 Sync-Rx, Ltd. Identification and presentation of device-to-vessel relative motion
US9629571B2 (en) 2007-03-08 2017-04-25 Sync-Rx, Ltd. Co-use of endoluminal data and extraluminal imaging
US9375164B2 (en) 2007-03-08 2016-06-28 Sync-Rx, Ltd. Co-use of endoluminal data and extraluminal imaging
EP2129284A4 (en) 2007-03-08 2012-11-28 Sync Rx Ltd Imaging and tools for use with moving organs
US10716528B2 (en) 2007-03-08 2020-07-21 Sync-Rx, Ltd. Automatic display of previously-acquired endoluminal images
US9968256B2 (en) 2007-03-08 2018-05-15 Sync-Rx Ltd. Automatic identification of a tool
EP2358269B1 (en) 2007-03-08 2019-04-10 Sync-RX, Ltd. Image processing and tool actuation for medical procedures
WO2009153794A1 (en) 2008-06-19 2009-12-23 Sync-Rx, Ltd. Stepwise advancement of a medical tool
US8455459B2 (en) 2007-08-02 2013-06-04 Medicis Pharmaceutical Corporation Method of applying an injectable filler
EP2313122B1 (en) * 2008-07-17 2019-03-06 Micell Technologies, Inc. Drug delivery medical device
US8039433B2 (en) * 2008-08-19 2011-10-18 Warsaw Orthopedic, Inc. Osteogenic compositions containing a coloring agent
US9144394B2 (en) 2008-11-18 2015-09-29 Sync-Rx, Ltd. Apparatus and methods for determining a plurality of local calibration factors for an image
US8855744B2 (en) 2008-11-18 2014-10-07 Sync-Rx, Ltd. Displaying a device within an endoluminal image stack
US10362962B2 (en) 2008-11-18 2019-07-30 Synx-Rx, Ltd. Accounting for skipped imaging locations during movement of an endoluminal imaging probe
US9095313B2 (en) 2008-11-18 2015-08-04 Sync-Rx, Ltd. Accounting for non-uniform longitudinal motion during movement of an endoluminal imaging probe
US9101286B2 (en) 2008-11-18 2015-08-11 Sync-Rx, Ltd. Apparatus and methods for determining a dimension of a portion of a stack of endoluminal data points
US11064903B2 (en) 2008-11-18 2021-07-20 Sync-Rx, Ltd Apparatus and methods for mapping a sequence of images to a roadmap image
US9974509B2 (en) 2008-11-18 2018-05-22 Sync-Rx Ltd. Image super enhancement
HUP1000385A2 (en) 2010-07-21 2012-01-30 Medicontur Orvostechnikai Kft Alkane diol derivatives preparation thereof and based on them
US9677042B2 (en) 2010-10-08 2017-06-13 Terumo Bct, Inc. Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
JP5998201B2 (en) 2011-04-20 2016-09-28 カービラン セラピューティクス， インコーポレイテッド IN-SITU gel-forming composition
JP6099640B2 (en) 2011-06-23 2017-03-22 シンク−アールエックス，リミティド Lumen background sharpening
EP2734261B1 (en) 2011-07-18 2018-02-21 Mor-Research Applications Ltd. A device for adjusting the intraocular pressure
AU2012328415B2 (en) * 2011-10-28 2016-03-17 Baxter Healthcare Sa Nonaqueous compositions for bone hemostasis, and methods for their use and manufacture
JP6134789B2 (en) 2012-06-26 2017-05-24 シンク−アールエックス，リミティド Image processing related to flow in luminal organs
WO2014165917A1 (en) * 2013-04-10 2014-10-16 The University Of Melbourne Biodegradable network polymers for regenerative medicine and tissue engineering
EP3068867B1 (en) 2013-11-16 2018-04-18 Terumo BCT, Inc. Expanding cells in a bioreactor
CN106232800B (en) 2014-03-25 2020-07-03 泰尔茂比司特公司 Passive replacement of media
EP3198006B1 (en) 2014-09-26 2021-03-24 Terumo BCT, Inc. Scheduled feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
CN109415696A (en) 2016-05-25 2019-03-01 泰尔茂比司特公司 Cell amplification
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11096781B2 (en) 2016-08-01 2021-08-24 Edwards Lifesciences Corporation Prosthetic heart valve
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
WO2018184028A2 (en) 2017-03-31 2018-10-04 Terumo Bct, Inc. Cell expansion
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
CN108498905B (en) * 2018-04-03 2024-08-06 广州迈普再生医学科技股份有限公司 Chamber mirror type spray head for duplex mixing injector and chamber mirror type duplex mixing injector
EP3706619B1 (en) 2017-11-09 2024-04-24 ConvaTec Technologies Inc. Ostomy monitoring system
ES2997248T3 (en) * 2018-08-09 2025-02-14 Gambro Lundia Ab Method for detection of flow obstruction in an extracorporeal circuit, apparatus and computer program
USD893514S1 (en) 2018-11-08 2020-08-18 11 Health And Technologies Limited Display screen or portion thereof with graphical user interface
US20200254103A1 (en) * 2019-02-11 2020-08-13 John Mee Method for treating neurological conditions and improving human cognition
MX2023001747A (en) 2020-08-24 2023-04-25 Edwards Lifesciences Corp BALLOON LINING FOR AN EXPANDABLE PROSTHETIC HEART VALVE DELIVERY DEVICE.
JP2023545504A (en) 2020-10-15 2023-10-30 コンバテック・テクノロジーズ・インコーポレイテッド Ostomy systems and methods
JP7705950B2 (en) 2021-03-23 2025-07-10 テルモ ビーシーティー、インコーポレーテッド How to grow cells
CN113281317B (en) * 2021-05-14 2022-04-29 北京指真生物科技有限公司 A kind of coding microsphere containing cyanine compound and its preparation method and application
US12209689B2 (en) 2022-02-28 2025-01-28 Terumo Kabushiki Kaisha Multiple-tube pinch valve assembly
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device
CN115382028A (en) * 2022-09-19 2022-11-25 郑州大学第一附属医院 A kind of degradable stapler material and its preparation method and application
CN120712074A (en) * 2023-01-25 2025-09-26 北卡罗莱纳州立大学 Compositions and methods related to inhalable therapeutic compositions
JP7602090B1 (en) * 2024-06-10 2024-12-17 真由美 大石 Wound scaffolds for inhibiting scarring of biological tissue
CN118903564B (en) * 2024-09-02 2025-11-04 嘉兴睿清医疗科技有限公司 A hydroxyapatite composite polyester microsphere, its preparation method and application

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1250166B1 (en) * 2000-01-25 2010-03-17 Edwards Lifesciences Corporation Delivery systems for treatment of restenosis and anastomotic intimal hyperplasia
CA2445763A1 (en) * 2001-05-01 2002-11-07 Angiotech Pharmaceuticals Inc. Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions
US20030207907A1 (en) * 2002-05-03 2003-11-06 Iversen Patrick L. Delivery of microparticle-conjugated drugs for inhibition of stenosis
US20050208095A1 (en) * 2003-11-20 2005-09-22 Angiotech International Ag Polymer compositions and methods for their use

Also Published As

Publication number Publication date
CA2536181A1 (en) 2005-06-09
WO2005051316A2 (en) 2005-06-09
AU2004293071A1 (en) 2005-06-09
JP2007517543A (en) 2007-07-05
WO2005051452A2 (en) 2005-06-09
EP1684819A2 (en) 2006-08-02
WO2005051316A3 (en) 2010-01-28

Similar Documents

Publication Publication Date Title
IL174641A0 (en) Polymeric pharmaceutical compositions containing an anti-fibrotic agent
GB0320382D0 (en) Pharmaceutical compositions
HRP20150039T1 (en) Pharmaceutical formulations containing methylnaltrexone
GB0327723D0 (en) Pharmaceutical compositions
GB0300427D0 (en) Pharmaceutical composition
HU0301154D0 (en) Pharmaceutical composition
GB0300531D0 (en) Pharmaceutical compositions
EP1648411A4 (en) Pharmaceutical compositions
GB0307866D0 (en) Pharmaceutical composition
EP1699458A4 (en) Pharmaceutical composition
GB0316206D0 (en) Pharmaceutical formulation
GB0329232D0 (en) Pharmaceutical composition
ZA200605080B (en) Pharmaceutical compositions
GB0317663D0 (en) Pharmaceutical composition
PL378011A1 (en) Powder pharmaceutical compositions
EP1655029A4 (en) Medicinal compositions
GB0300885D0 (en) Pharmaceutical composition
EP1600445A4 (en) Medicinal composition
IL176077A0 (en) 1-n-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them
GB0306933D0 (en) Pharmaceutical composition
GB0305579D0 (en) Pharmaceutical compositions
GB0307869D0 (en) Pharmaceutical composition
ZA200601232B (en) 3-Aryl-4-hydroxyfuranone compounds and pharmaceutical and veterinary compositions containing them
GB0307867D0 (en) Pharmaceutical composition
GB0307862D0 (en) Pharmaceutical composition